Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05956951 · ClinicalTrials.gov registry record · NA

Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation

A NA study of Schizophrenia, sponsored by Fabio Ferrarelli.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT05956951 is a NA study of Schizophrenia that is actively recruiting participants, run by Fabio Ferrarelli. The registered enrollment target is 200 participants, roughly in line with the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05956951, a NA study of Schizophrenia, is actively recruiting participants, sponsored by Fabio Ferrarelli.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to identify differences in brain activity during sleep between health individuals and individuals with schizophrenia, schizophreniform, or schizoaffective disorder. This study will also investigate whether tones played during deep sleep can enhance specific features of sleep and whether enhancing such features is related to an improvement in cognitive performance.

Conditions Studied

Interventions

  • DEVICE Closed-loop auditory stimulation
  • DEVICE Sham auditory stimulation

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-07-20
Est. Completion 2028-06
Phase NA

Sponsor

Fabio Ferrarelli

2 total trials

What the Registry Record Tells You About NCT05956951

The ClinicalTrials.gov registry entry for NCT05956951 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 218-participant average among 315 other Schizophrenia trials with a reported enrollment target. The listed sponsor is Fabio Ferrarelli, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Closed-loop auditory stimulation is the first listed.

NCT05956951 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05956951 about?

NCT05956951 is a clinical study titled "Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation". The purpose of this research is to identify differences in brain activity during sleep between health individuals and individuals with schizophrenia, schizophreniform, or schizoaffective disorder. This study will also investigate whether tones played during deep sleep can enhance specific features o...

What is the current status of trial NCT05956951?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-07-20. Estimated completion is 2028-06.

What conditions does trial NCT05956951 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT05956951?

The interventions under investigation include: Closed-loop auditory stimulation (DEVICE), Sham auditory stimulation (DEVICE).

Who is sponsoring clinical trial NCT05956951?

This trial is sponsored by Fabio Ferrarelli, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05956951 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.